Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins
- 1 August 1987
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 6 (4) , 456-459
- https://doi.org/10.1007/bf02013110
Abstract
To assess the clinical importance of emergence of beta-lactam resistance caused by stable derepression of chromosomal beta-lactamases, sequential cultures from patients treated with expanded-spectrum cephalosporins were monitored for the persistence of bacteria possessing these enzymes. Antibiotic susceptibilities and beta-lactamase production before and after cefoxitin induction were determined in sequential isolates of individual bacterial strains. Of 49 strains isolated from 44 patients, 25 strains (51%) were eradicated by cephalosporin therapy, 17 strains (35%) persisted with unchanged susceptibility in sequential cultures, and 7 strains (14%) from 7 patients developed multiple beta-lactam resistance during cephalosporin therapy. In 6 of the 7 strains, resistance was associated with stable derepression of beta-lactamases. In the patient group whose strains developed resistance, subsequent use of non-beta-lactam antibiotics was more frequent and mortality was higher.This publication has 20 references indexed in Scilit:
- Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1986
- Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1985
- Comparative analysis of conjugative plasmids mediating gentamicin resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1983
- Ceftriaxone therapy of serious bacterial infections in adultsAntimicrobial Agents and Chemotherapy, 1983
- Resistance to Cefamandole: Derepression of -Lactamases by Cefoxitin and Mutation in Enterobacter cloacaeThe Journal of Infectious Diseases, 1982
- beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatmentAntimicrobial Agents and Chemotherapy, 1981
- Insensitivity of peptidoglycan biosynthetic reactions to beta-lactam antibiotics in a clinical isolate of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1981
- Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-LactamasesAntimicrobial Agents and Chemotherapy, 1979
- Cefamandole Nafate Therapy of Respiratory Tract, Skin, and Soft Tissue Infections in 74 PatientsThe Journal of Infectious Diseases, 1978
- Susceptibility of Enterobacter to Cefamandole: Evidence for a High Mutation Rate to ResistanceAntimicrobial Agents and Chemotherapy, 1976